Clinical Research Detail Title Of Study A Phase II/III clinical Study to Evaluate the Immunogenicity and Safety of Three Formulations of Monovalent H1N1 Influenza A (2009) Virus Vaccine, Manufactured by Panacea Biotec Ltd., in Healthy Pediatric Population 6 - 35 Months of Age. Disease Condition Immunogenicity and safety of study vaccine in healthy pediatric subjects 6-35 months of age. Phase of Trial Phase-2 & 3 Discipline Immunology Start date of Trial 4/26/2010 Closing Date of Trial 7/26/2010 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]